Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stem cells may boost islet transplants for chronic pancreatitis patients

NCT ID NCT05095532

First seen Feb 05, 2026 · Last updated May 22, 2026 · Updated 14 times

Summary

This early-phase trial tests whether adding a patient's own bone marrow stem cells to an islet transplant can help preserve insulin production and reduce diabetes after pancreas removal for chronic pancreatitis. About 42 adults will be randomly assigned to receive stem cells or standard care, and followed for one year. The goal is to improve blood sugar control and possibly reduce the need for insulin injections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.